Market Report, "Lithuania Pharmaceuticals & Healthcare Report Q3 2013", Published
Unfavourable economic headwinds will continue to pose downside risks to our pharmaceutical market forecasts for the Lithuanian market, especially given that out-of-pocket payments continue to represent a substantial proportion of total drug expenditure. Nevertheless, volume demand will continue to be supported by demographic and epidemiological factors.
View full press release